TwoStep Therapeutics
- Biotech or pharma, therapeutic R&D
TwoStep Therapeutics is a venture-backed spinout from Stanford University developing a pipeline built around a unique tumor-targeting polyspecific integrin-binding peptide (PIP) that can selectively bind several targets that are highly expressed on solid tumors. The company leverages this technology to create targeted cancer therapies for cytotoxic drug delivery, radioligand therapy, and immunotherapy. For more information, visit www.twosteptx.com.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}